Bristol-Myers Squibb to Use Sequenom s MassArray Tech to Investigate Disease Targets | GenomeWeb

NEW YORK, July 10 - Bristol-Myers Squibb will use Sequenom's MassArray technology and DNA sample library to evaluate specific undisclosed disease targets, Sequenom said.


Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.